Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2017 filings

All 43 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2017, sourced directly from the official regulator.

43 Filings
2017 Period
2017 filings (43)
Filing Released Lang
VivaGel BV treatment clinical submission under rolling NDA 3 pages 172.3KB
Regulatory Filings
2017-12-20 English
Appendix 3B 9 pages 194.5KB
Capital/Financing Update
2017-12-10 English
Change in Director's Interest Notice - J Fairley 2 pages 252.6KB
Director's Dealing
2017-12-10 English
Change in Director's Interest Notice - R Thomas 2 pages 252.6KB
Director's Dealing
2017-12-04 English
AGM - Chairman address and CEO presentation 45 pages 6.2MB
AGM Information
2017-11-28 English
AGM Results 2 pages 144.1KB
Declaration of Voting Results & Voting Rights Announcements
2017-11-28 English
Amended Constitution 57 pages 919.8KB
Governance Information
2017-11-28 English
NDA submission for VivaGel BV in the US 2 pages 160.2KB
Regulatory Filings
2017-11-20 English
Change in Director's Interest Notice - J Fairley 2 pages 74.9KB
Director's Dealing
2017-11-07 English
Change in Director's Interest Notice - R Thomas 2 pages 122.8KB
Director's Dealing
2017-10-30 English
Notice of Annual General Meeting/Proxy Form 17 pages 658.4KB
AGM Information
2017-10-26 English
Appendix 4C - Quarterly Cashflow Report 6 pages 196.5KB
Interim / Quarterly Report
2017-10-25 English
VivaGel BV granted marketing approval in Australia 3 pages 88.5KB
Regulatory Filings
2017-10-24 English
Shareholder Update October 2017 4 pages 1.3MB
Interim / Quarterly Report
2017-10-17 English
Appendix 3B 9 pages 112.4KB
Share Issue/Capital Change
2017-10-11 English
Starpharma and Peter Mac Cancer Centre awarded DEP Grant 2 pages 61.2KB
Regulatory Filings
2017-10-08 English
Appendix 3B 8 pages 190.5KB
Share Issue/Capital Change
2017-10-04 English
Change in Director's Interest Notice - J Fairley 3 pages 132.7KB
Director's Dealing
2017-10-04 English
Notification of AGM date 1 page 119.7KB
AGM Information
2017-10-01 English
AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor 2 pages 143.5KB
Regulatory Filings
2017-09-27 English
DEP docetaxel positive phase 1 results, phase 2 commences 6 pages 372.8KB
Regulatory Filings
2017-09-21 English
Annual report and full year financial results 95 pages 1.9MB
Annual Report
2017-08-27 English
Appendix 4G - Corporate Governance Statement 9 pages 192.9KB
Governance Information
2017-08-27 English
Starpharma to present at Finance News Network Investor Event 2 pages 123.7KB
Investor Presentation
2017-08-23 English
Appendix 3B 8 pages 189.4KB
Share Issue/Capital Change
2017-08-20 English
Starpharma and Monash awarded STEM Business Fellowships 2 pages 139.0KB
Regulatory Filings
2017-08-08 English
Successful VivaGel Phase 3 results and NDA planned for rBV 16 pages 435.2KB
Capital/Financing Update
2017-08-06 English
Appendix 4C - Quarterly Cashflow Report 6 pages 168.8KB
Interim / Quarterly Report
2017-07-18 English
VivaGel BV phase 3 results timing and commercialisation 2 pages 178.6KB
Capital/Financing Update
2017-07-03 English
Shareholder Update July 2017 4 pages 728.2KB
Capital/Financing Update
2017-07-03 English
Starpharma sells Agrochemicals business to Agrium for $35M 3 pages 185.2KB
Capital/Financing Update
2017-06-13 English
Sale of Agrochemicals Business Investor Presentation 12 pages 817.4KB
Investor Presentation
2017-06-13 English
Appendix 3B 10 pages 189.7KB
Capital/Financing Update
2017-06-13 English
DEP irinotecan outperforms irinotecan in cancer models 6 pages 359.2KB
Regulatory Filings
2017-06-05 English
Starpharma receives DEP milestone from AstraZeneca 2 pages 178.2KB
Capital/Financing Update
2017-06-01 English
Appendix 4C - Quarterly Cashflow Report 6 pages 124.4KB
Interim / Quarterly Report
2017-04-27 English
AstraZeneca DEP candidate advance triggers milestone to SPL 3 pages 95.2KB
Capital/Financing Update
2017-04-19 English
VivaGel BV phase 3 trials for prevention of BV completed 4 pages 342.8KB
Capital/Financing Update
2017-03-29 English
Interim Report and Half-Year Financial Results 23 pages 635.4KB
Interim / Quarterly Report
2017-02-26 English
Appendix 4C - Quarterly Cashflow Report 6 pages 124.7KB
Interim / Quarterly Report
2017-01-30 English
Appendix 3B 10 pages 117.4KB
Share Issue/Capital Change
2017-01-24 English
Shareholder Update January 2017 4 pages 770.5KB
Management Reports
2017-01-18 English
VivaGel BV granted QIDP and Fast Track designation by US FDA 3 pages 92.4KB
Regulatory Filings
2017-01-11 English